Related Experiment Video
Updated: Jun 27, 2026

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
Intracellular and extracellular serpins modulate lung disease
1UPMC Newborn Medicine Program, Children's Hospital of Pittsburgh and Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. rsidja@mwri.magee.edu
Pulmonary diseases arise from an imbalance between peptidases and their inhibitors. This review focuses on serine peptidase inhibitors (serpins), their lung function, and therapeutic potential.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Molecular Biology
Background:
- An imbalance between peptidases and their inhibitors is linked to pulmonary diseases in adults and neonates.
- Serine peptidase inhibitors (serpins) are the primary source of antipeptidase activity in the lung.
Purpose of the Study:
- To review the mechanism of serpin inhibition.
- To elucidate the roles of serpins in normal and pathological lung conditions.
- To explore the therapeutic potential of serpins in treating lung diseases.
Main Methods:
- Literature review of serpin function and inhibition mechanisms.
- Analysis of serpin roles in various lung pathologies.
- Evaluation of serpins as therapeutic targets.
Main Results:
- Serpins employ a specific mechanism to inhibit serine peptidases.
- Dysregulation of serpins contributes to the pathogenesis of several lung diseases.
- Serpins show promise as agents for treating pulmonary conditions.
Conclusions:
- Understanding serpin mechanisms is crucial for addressing peptidase-inhibitor imbalances in lung disease.
- Serpins represent a significant area for therapeutic development in respiratory medicine.
More Related Videos
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
09:00Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia II: Pathophysiology
Transcellular Transport of Solutes
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pneumonia I: Introduction
Pulmonary Edema II: Pathophysiology